Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Who Needs DSM-5? A Strong Warning Comes From Professional Counselors
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Who Needs DSM-5? A Strong Warning Comes From Professional Counselors
Who Needs DSM-5? A Strong Warning Comes From Professional Counselors
The following are direct quotes from Dr Jones' email expressing the ACA (American Counseling Association) concerns about the proposed revisions for DSM-5:
- Lowering of diagnostic thresholds.
- Consequences of the proposed revisions.
- Excessive complexity of the dimensional assessments.
- Quality of proposed scales.
- Counselors have been excluded from its development process.
- Finally, we get to the crucial (and still open) question of whether counselors should, and need to, use DSM-5.
Complete Article here ---> Psychiatric Times
The following are direct quotes from Dr Jones' email expressing the ACA (American Counseling Association) concerns about the proposed revisions for DSM-5:
- Lowering of diagnostic thresholds.
- Consequences of the proposed revisions.
- Excessive complexity of the dimensional assessments.
- Quality of proposed scales.
- Counselors have been excluded from its development process.
- Finally, we get to the crucial (and still open) question of whether counselors should, and need to, use DSM-5.
Complete Article here ---> Psychiatric Times
Similar topics
» FDA Warning: Counterfeit Adderall 30 mg Tablets
» FDA Adds Heart Warning to Quetiapine's Label
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
» FDA Warning: Serious Allergic Reactions Reported With Saphris (Asenapine Maleate)
» FDA Adds Heart Warning to Quetiapine's Label
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
» FDA Warning: Serious Allergic Reactions Reported With Saphris (Asenapine Maleate)
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin